Skip to main content

EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study

Enrolling by invitation · Not applicable · NCT05610787

Conditions: Heart Failure, Transplant, Failure, Heart, Congenital Heart Disease

At a glance

Research payments reported, 2025
$859,620
U.S. investigators named
11
Sites paid
11
Planned or actual enrollment
40

About the trial

Sponsor
Berlin Heart, Inc
Tested
EXCOR Active Driving System for Pediatric VAD (device)
Dates
Started 2022-11-14; completion 2027-01
Results posted
Not yet

The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Driving System while being used with the approved EXCOR Pediatric Ventricular Assist Device. EXCOR Active Driving System is intended for use with the approved EXCOR Pediatric VAD. The EXCOR Pediatric VAD is intended to provide mechanical circulatory support as a bridge to cardiac transplantation for pediatric patients. Pediatric candidates with severe isolated left ventricular or biventricular dysfunction who are candidates for cardiac transplant and require circulatory support may be treated using the EXCOR Pediatric. EXCOR Active is intended for use i…

From ClinicalTrials.gov, last updated 2026-10-29. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Berlin Heart Inc reported $859,620 in research payments for this study in 2025 (25 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.